Observe Medical Asa (OBSRV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -0.829x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.83 Million ≈ $-2.61 Million USD) by net assets (Nkr29.96 Million ≈ $3.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OBSRV stock market capitalisation for the company's overall valuation and market capitalisation.
Observe Medical Asa - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency. Explore earnings quality score of Observe Medical Asa to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GigaMedia Limited
F:GIFN
|
N/A |
|
Khind Holdings Bhd
KLSE:7062
|
0.064x |
|
Miwon Chemical
KO:134380
|
0.065x |
|
Taruga Minerals Ltd
AU:TAR
|
-0.126x |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
-0.049x |
|
Toleranzia AB
ST:TOL
|
-0.023x |
|
YXT.COM GROUP HOLDING LIMITED American Depository Shares
NASDAQ:YXT
|
-0.280x |
|
Minbos Resources Ltd
AU:MNB
|
-0.118x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2025)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. View Observe Medical Asa stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr29.96 Million ≈ $3.15 Million |
Nkr-24.83 Million ≈ $-2.61 Million |
-0.829x | +34.86% |
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
Nkr-30.68 Million ≈ $-3.23 Million |
-1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
Nkr-24.45 Million ≈ $-2.57 Million |
-0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
Nkr-51.37 Million ≈ $-5.41 Million |
-0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
Nkr-22.13 Million ≈ $-2.33 Million |
1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
Nkr-21.64 Million ≈ $-2.28 Million |
-1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
Nkr-13.97 Million ≈ $-1.47 Million |
-0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
Nkr-8.36 Million ≈ $-880.11K |
-0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
Nkr-9.83 Million ≈ $-1.03 Million |
-0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
Nkr-10.45 Million ≈ $-1.10 Million |
-0.711x | -- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more